Literature DB >> 7460486

Inhibition of theophylline metabolism by long-term allopurinol administration.

R L Manfredi, E S Vesell.   

Abstract

Administration of an oral dose of allopurinol (300 mg every 12 hr) for 14 consecutive days increased the mean theophylline area under the curve (AUC) 27% and mean theophylline half-life (t1/2) 25%, whereas the mean theophylline clearance (Cl) decreased 21%. Allopurinol did not alter either apparent volume of distribution (aVd) or gastrointestinal absorption (Cmax and tmax) of theophylline. After 28 consecutive days of allopurinol administration, theophylline disposition was the same as that on day 14. Thus, given in a dose of 300 mg every 12 hr for 14 or 28 days, allopurinol inhibits theophylline metabolism, despite the failure of allopurinol in lower doses given for only 7 days to alter theophylline disposition. These results emphasize the need to investigate several different doses and durations of administration within therapeutic ranges before firm conclusions can be drawn concerning the influence of one drug on the disposition of another.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7460486     DOI: 10.1038/clpt.1981.36

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  19 in total

Review 1.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

2.  Seizures from theophylline use.

Authors:  R G Dellen
Journal:  West J Med       Date:  1983-03

3.  Theophylline and isoniazid.

Authors:  J R Thompson; T H Self
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

Review 4.  Adverse reactions and interactions with theophylline.

Authors:  M H Skinner
Journal:  Drug Saf       Date:  1990 Jul-Aug       Impact factor: 5.606

5.  Lack of effect of repirinast on the pharmacokinetics of theophylline in asthmatic patients.

Authors:  K Takagi; T Kuzuya; T Horiuchi; M Nadai; R Apichartpichean; Y Ogura; T Hasegawa
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 6.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

7.  Attenuation of rifampicin-induced theophylline metabolism by diltiazem/rifampicin coadministration in healthy volunteers.

Authors:  G I Adebayo; A Akintonwa; A F Mabadeje
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 8.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 9.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

Review 10.  Pharmacokinetic drug interactions with theophylline.

Authors:  J H Jonkman; R A Upton
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.